25-valent pneumococcal conjugate vaccine (Inventprise)

25价肺炎球菌结合疫苗 (Inventprise)

Report date: 2024/01/10 15:21:25

Base Information

Drug Name25-valent pneumococcal conjugate vaccine (Inventprise)
Drug Alias NameIVT25 Valent PEGylatedIVT-Pneumo Conj. Vacc. -025IVT25IVT-PCV-25PCV25V +[6] 
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccineVaccines > Vaccine type > Multivalent vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPhilippines
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInventprise LLC
China Registration ClassN/A

Develop Information

Active CompaniesInventprise LLC
Inactive CompaniesN/A
Active IndicationsPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A